Senetek PLC Annual Meeting to Be Webcast By CCBN and at Company Web Site
NAPA, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTKY - news), senetekplc.com , a biopharmaceutical company that develops products in two key markets, skincare/dermatologicals and sexual dysfunction, will hold its annual meeting at the Le Parker Meridien hotel in New York City on January 29 at 10 a.m. Eastern Standard Time.
The annual meeting is being webcast by CCBN and also can be accessed at Senetek PLC's Web site at senetekplc.com . Please check the Web sites for broadcast information.
The webcast will be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network such as America Online's Personal Finance Channel.
Institutional investors can access the call via CCBN's password protected event management site, StreetEvents ( www.streetevents.com ). StreetEvents allows institutional investors to identify, organize, and track the hundreds of conference calls that occur each day during earnings season, to download events of interest to their Outlook calendar, and to RSVP to events online.
Senetek PLC, headquartered in Napa, California, is a science driven biopharmaceutical company engaged in the development of skincare/dermatological and sexual dysfunction products. Kinetin, the Company's patented anti-aging skincare technology, has been licensed to leading cosmetic and dermatological companies worldwide. Invicorp(TM) is Senetek's technology for the treatment of Erectile Dysfunction, a condition suffered by more than 100 million men worldwide. To learn more about Senetek, visit the Company's Website at senetekplc.com .
Visit SENETEK PLC's Website at senetekplc.com
This news release may contain statements that may be considered ``forward looking statements'' under the Federal securities laws, including statements concerning the revenue and licensing income we may receive in the future under licenses of our products, and the additional licensing agreements we may enter into during 2002. No forward-looking statement we make is a guarantee of future performance or events. Actual results or events may differ materially from those in the forward-looking statements as a result of various factors, including the risks and uncertainties described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2001 filed with the Securities and Exchange Commission.
SOURCE: Senetek PLC |
